Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study

BACKGROUND: Various botulinumtoxinA formulations are approved for glabellar lines treatment worldwide, including abobotulinumtoxinA (Dysport(®)). OBJECTIVES: Assess abobotulinumtoxinA superiority versus placebo and non-inferiority versus active comparator (onabotulinumtoxinA; Botox(®)), for the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yan, Fang, Fang, Lai, Wei, Li, Chengxin, Li, Li, Liu, Quanzhong, Lu, Jianyun, Pang, Xiaowen, Sun, Jiaming, Shi, Xiaofeng, Picaut, Philippe, Prygova, Inna, Andriopoulos, Bill, Sun, Qiuning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944721/
https://www.ncbi.nlm.nih.gov/pubmed/36536093
http://dx.doi.org/10.1007/s00266-022-03164-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944721/
https://www.ncbi.nlm.nih.gov/pubmed/36536093
http://dx.doi.org/10.1007/s00266-022-03164-3

Ejemplares similares